ClinVar Miner

Submissions for variant NM_000191.3(HMGCL):c.202_203CT[2] (p.Ser69fs) (rs752137615)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000012732 SCV000790562 likely pathogenic Deficiency of hydroxymethylglutaryl-CoA lyase 2017-03-29 criteria provided, single submitter clinical testing
GeneDx RCV000185970 SCV000238928 pathogenic not provided 2017-07-13 criteria provided, single submitter clinical testing The c.206_207delCT variant has been reported previously in association with HMG-CoA lyase deficiency (Mitchell et al., 1993; Menao et al. 2009). The c.206_207delCT variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The deletion causes a frameshift starting with codon Serine 69, changes this amino acid to a Cysteine residue and creates a premature Stop codon at position 11 of the new reading frame, denoted p.Ser69CysfsX11. This variant is predicted to cause loss of normal protein function either through premature protein truncation or nonsense-mediated mRNA decay. In summary, we interpret c.206_207delCT to be a pathogenic variant.
OMIM RCV000012732 SCV000032967 pathogenic Deficiency of hydroxymethylglutaryl-CoA lyase 1993-02-25 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.